Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
125.40    -0.40 (-0.32%)
Bid:
124.80
Ask:
126.80
Spread: 2.00 (1.603%)
Market Cap: £390.45m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

Directorate Change

10 Oct 2011 07:00

RNS Number : 8183P
Michael Page International PLC
10 October 2011
 



10 October 2011

Michael Page International plc

 

Directorate Change

 

Michael Page International plc ("Michael Page"), the specialist recruitment consultancy, announces that Sir Adrian Montague will retire as Chairman of the Board on 31 December 2011 following the completion of a planned succession process, and Robin Buchanan, who joined the Board as an independent Non-Executive Director in August, will succeed him as Chairman.

 

Sir Adrian joined the Board of Michael Page in February 2001 as a Non-Executive Director and was appointed Chairman in May 2002. Sir Adrian remains Chairman of the private equity firm 3i, Anglian Water Group Limited, Hurricane Exploration plc, an oil and gas exploration company and of CellMark AB, the international forest products marketing group based in Gothenburg. He is also Chairman of the Advisory Board of the Green Investment Bank.

 

Robin Buchanan is a Senior Adviser to Bain & Company Inc ("Bain"), having been the Managing Partner and then the Senior Partner of Bain in the UK between 1990 and 2007. He is also a Non-Executive Director of Schroders plc, the global asset management company and LyondellBasell NV, the NYSE global petro-chemicals company. He is a member of the Trilateral Commission and of the International Advisory Council of Recipco. He is also an advisor to Coller Capital Ltd.

 

He served previously as Dean and then President of the London Business School, as non-executive director of Liberty International plc and also of Shire plc.

 

Steve Ingham, Chief Executive Officer said:

"Sir Adrian's ten year Chairmanship has overseen the development of the Group into a global business, now operating in thirty two countries. I would like to thank Sir Adrian for his advice, guidance and support as Chairman and I know he will be missed by his colleagues in the Group.

 

"We are delighted that Robin has agreed to Chair the Board. He has broad-ranging and extensive international experience and his entrepreneurial, team-orientated approach fits well with the Michael Page culture."

 

Robin Buchanan said:

"Michael Page has many great strengths, including a highly respected global brand, impressive competitive positioning in the world's growth markets, a strong balance sheet and a 'make it happen' culture. It is a privilege to be asked to serve as Chairman of Michael Page and to work with the Board and management team who have helped make the company so successful."

 

 

There are no disclosures to be made under Listing Rule 9.6.13 in respect of either Sir Adrian Montague or Robin Buchanan.

 

- Ends -

 

Enquiries:

FTI Consulting

Richard Mountain / Sophie Moate 020 7269 7291

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAZDLFBFBFFFBZ
Date   Source Headline
28th May 20261:22 pmRNSResult of AGM
7th May 20263:00 pmRNSBoard change
14th Apr 20267:00 amRNSFIRST QUARTER 2026 TRADING UPDATE
13th Apr 202610:51 amRNSAnnual Report & Accounts & Notice of AGM
10th Apr 202612:34 pmRNSNotice of First Quarter 2026 Trading Update
30th Mar 20261:51 pmRNSDirector/PDMR Shareholding
19th Mar 20269:18 amRNSHolding(s) in Company
17th Mar 20269:44 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
9th Mar 20269:21 amRNSHolding(s) in Company
5th Mar 20261:22 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSFull Year Results for the Year Ended 31 Dec 2025
4th Mar 202611:43 amRNSPageGroup plc - Board Changes
2nd Mar 20262:58 pmRNSNotice of 2025 Full Year Results
17th Feb 202612:50 pmRNSHolding(s) in Company
10th Feb 20263:55 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFOURTH QUARTER 2025 TRADING UPDATE
9th Jan 202610:23 amRNSNotice of Q4 and Full Year 2025 Trading Update
17th Dec 20252:17 pmRNSHolding(s) in Company
26th Nov 20259:38 amRNSHolding(s) in Company
24th Oct 202511:31 amRNSHolding(s) in Company
15th Oct 20257:00 amRNSTHIRD QUARTER 2025 TRADING UPDATE
13th Oct 202511:03 amRNSNotice of Third Quarter 2025 Trading Update
8th Oct 202511:31 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSHalf Year Results for the Period Ended 30 June 25
7th Aug 20259:58 amRNSNotice of 2025 Half Year Results
10th Jul 20257:00 amRNSSecond Quarter 2025 Trading Update
8th Jul 20255:03 pmRNSNotice of Second Quarter 2025 Trading Update
11th Jun 202511:45 amRNSPageGroup plc - Board Changes
9th Jun 20254:11 pmRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
4th Jun 202510:56 amRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSResult of AGM
9th Apr 20257:00 amRNSFirst Quarter 2025 Trading Update
24th Mar 20252:02 pmRNSDirector Declaration
19th Mar 20251:18 pmRNSHolding(s) in Company
18th Mar 20251:41 pmRNSDirector/PDMR Shareholding
18th Mar 20251:35 pmRNSDirector/PDMR Shareholding
14th Mar 20251:10 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFull Year Results for the Year Ended 31 Dec 2024
4th Mar 20259:40 amRNSNotice of 2024 Full Year Results
6th Feb 20259:44 amRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSFourth Quarter 2024 Trading Update
9th Jan 20254:25 pmRNSNotice of Q4 and Full Year 2024 Trading Update
31st Oct 20243:37 pmRNSNotification of Interests of Directors
14th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
10th Oct 202411:50 amRNSNotice of Third Quarter 2024 Trading Update
8th Aug 20247:00 amRNSHalf Year Results for the Period Ended 30 June 24

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.